189 related articles for article (PubMed ID: 34682233)
1. Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell Transplantation.
Glampedakis E; Roth R; Masouridi-Levrat S; Chalandon Y; Mamez AC; Giannotti F; Van Delden C; Neofytos D
J Fungi (Basel); 2021 Sep; 7(10):. PubMed ID: 34682233
[TBL] [Abstract][Full Text] [Related]
2. Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?
Roth RS; Masouridi-Levrat S; Chalandon Y; Mamez AC; Giannotti F; Riat A; Fischer A; Poncet A; Glampedakis E; Van Delden C; Kaiser L; Neofytos D
Open Forum Infect Dis; 2022 Jan; 9(1):ofab596. PubMed ID: 34993259
[TBL] [Abstract][Full Text] [Related]
3. Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections.
Roth RS; Masouridi-Levrat S; Giannotti F; Mamez AC; Glambedakis E; Lamoth F; Bochud PY; Erard V; Emonet S; Van Delden C; Kaiser L; Chalandon Y; Neofytos D
Mycoses; 2022 Feb; 65(2):199-210. PubMed ID: 34936143
[TBL] [Abstract][Full Text] [Related]
4. Antifungal Treatment Duration in Hematology Patients With Invasive Mold Infections: A Real-life Update.
Portillo V; Ragozzino S; Stavropoulou E; El-Khoury C; Bochud PY; Lamoth F; Khanna N; Neofytos D
Open Forum Infect Dis; 2024 May; 11(5):ofae201. PubMed ID: 38756760
[TBL] [Abstract][Full Text] [Related]
5. When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?
Roth RS; Masouridi-Levrat S; Giannotti F; Mamez AC; Morin S; van Delden C; Chalandon Y; Neofytos D
Mycoses; 2022 Nov; 65(11):1061-1067. PubMed ID: 35815918
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience.
Neofytos D; Treadway S; Ostrander D; Alonso CD; Dierberg KL; Nussenblatt V; Durand CM; Thompson CB; Marr KA
Transpl Infect Dis; 2013 Jun; 15(3):233-42. PubMed ID: 23432974
[TBL] [Abstract][Full Text] [Related]
7. Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation.
Rosillo C; Avila AM; Huang YT; Devlin S; Cho C; Montoro J; Maloy MA; Papanicolaou GA; Barba P; Perales MA
Transpl Infect Dis; 2018 Aug; 20(4):e12897. PubMed ID: 29668073
[TBL] [Abstract][Full Text] [Related]
8. Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma.
Hill JA; Dalai SC; Hong DK; Ahmed AA; Ho C; Hollemon D; Blair L; Maalouf J; Keane-Candib J; Stevens-Ayers T; Boeckh M; Blauwkamp TA; Fisher CE
Clin Infect Dis; 2021 Dec; 73(11):e3876-e3883. PubMed ID: 33119063
[TBL] [Abstract][Full Text] [Related]
9. A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Stern A; Su Y; Lee YJ; Seo S; Shaffer B; Tamari R; Gyurkocza B; Barker J; Bogler Y; Giralt S; Perales MA; Papanicolaou GA
Biol Blood Marrow Transplant; 2020 Jun; 26(6):1195-1202. PubMed ID: 32088367
[TBL] [Abstract][Full Text] [Related]
10. A Prospective, International Cohort Study of Invasive Mold Infections in Children.
Wattier RL; Dvorak CC; Hoffman JA; Brozovich AA; Bin-Hussain I; Groll AH; Castagnola E; Knapp KM; Zaoutis TE; Gustafsson B; Sung L; Berman D; Halasa NB; Abzug MJ; Velegraki A; Sharma TS; Fisher BT; Steinbach WJ
J Pediatric Infect Dis Soc; 2015 Dec; 4(4):313-22. PubMed ID: 26582870
[TBL] [Abstract][Full Text] [Related]
11. Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center.
Fukuda T; Boeckh M; Guthrie KA; Mattson DK; Owens S; Wald A; Sandmaier BM; Corey L; Storb RF; Marr KA
Biol Blood Marrow Transplant; 2004 Jul; 10(7):494-503. PubMed ID: 15205670
[TBL] [Abstract][Full Text] [Related]
12. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Moen MD; Lyseng-Williamson KA; Scott LJ
Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
[TBL] [Abstract][Full Text] [Related]
13. Incidence and Risk Factors for Breakthrough Invasive Mold Infections in Acute Myeloid Leukemia Patients Receiving Remission Induction Chemotherapy.
Patel HP; Perissinotti AJ; Patel TS; Bixby DL; Marshall VD; Marini BL
Open Forum Infect Dis; 2019 May; 6(5):ofz176. PubMed ID: 31123689
[TBL] [Abstract][Full Text] [Related]
14. Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography.
Akahoshi Y; Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y
Infect Dis (Lond); 2018 Apr; 50(4):280-288. PubMed ID: 29087731
[TBL] [Abstract][Full Text] [Related]
15. Association between the kinetics of cytomegalovirus reactivation evaluated in terms of the area under the curve of cytomegalovirus antigenemia and invasive mold infection during the post-engraftment phase after allogeneic hematopoietic stem cell transplantation.
Kimura SI; Takeshita J; Kawamura M; Kawamura S; Yoshino N; Misaki Y; Yoshimura K; Matsumi S; Gomyo A; Akahoshi Y; Tamaki M; Kusuda M; Kameda K; Wada H; Kawamura K; Sato M; Terasako-Saito K; Tanihara A; Nakasone H; Kako S; Kanda Y
Transpl Infect Dis; 2020 Oct; 22(5):e13387. PubMed ID: 32585736
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009).
Klingspor L; Saaedi B; Ljungman P; Szakos A
Mycoses; 2015 Aug; 58(8):470-7. PubMed ID: 26152371
[TBL] [Abstract][Full Text] [Related]
17. Evolution of antifungals for invasive mold infections in immunocompromised hosts, then and now.
Weiss ZF; Little J; Hammond S
Expert Rev Anti Infect Ther; 2023 May; 21(5):535-549. PubMed ID: 37104686
[TBL] [Abstract][Full Text] [Related]
18. Invasive mold infections in allogeneic bone marrow transplant recipients.
Baddley JW; Stroud TP; Salzman D; Pappas PG
Clin Infect Dis; 2001 May; 32(9):1319-24. PubMed ID: 11303267
[TBL] [Abstract][Full Text] [Related]
19. Clinical Considerations of Isavuconazole Administration in High-Risk Hematological Patients: A Single-Center 5-Year Experience.
Kronig I; Masouridi-Levrat S; Chalandon Y; Glampedakis E; Vernaz N; Van Delden C; Neofytos D
Mycopathologia; 2021 Dec; 186(6):775-788. PubMed ID: 34432216
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of solid organ transplant recipients with invasive aspergillosis and other mold infections.
Farges C; Cointault O; Murris M; Lavayssiere L; Lakhdar-Ghazal S; Del Bello A; Hebral AL; Esposito L; Nogier MB; Sallusto F; Iriart X; Charpentier E; Guitard J; Muscari F; Dambrin C; Porte L; Kamar N; Cassaing S; Faguer S
Transpl Infect Dis; 2020 Feb; 22(1):e13200. PubMed ID: 31630477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
